netFormulary
 Report : A-Z CDF items in Formulary 05/03/2021 22:13:04
[Back]
 
Section Status CDF Name
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios®
08.01.05 Non Formulary Cancer Drugs Fund Aflibercept Zaltrap®
08.01.05 Restricted Use Cancer Drugs Fund Atezolizumab  Tecentriq®
08.01.05 Formulary Cancer Drugs Fund Axicabtagene ciloleucel YESCARTA®
08.01.01 Formulary Cancer Drugs Fund Bendamustine Levact®
08.01.05 Non Formulary Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Non Formulary Cancer Drugs Fund Cabozantinib Cometriq®
08.01.05 Formulary Cancer Drugs Fund Cemiplimab Libtayo®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.01.03 Non Formulary Cancer Drugs Fund Clofarabine Evoltra®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar®
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx®
08.01.05 Formulary Cancer Drugs Fund Durvalumab Imfinzi®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy®
08.01.05 Formulary Cancer Drugs Fund Isatuximab Sarclisa®
08.02.04 Formulary Cancer Drugs Fund Ixazomib Ninlaro®
08.01.05 Restricted Use Cancer Drugs Fund Lapatinib Tyverb®
08.01.05 Formulary Cancer Drugs Fund Larotrectinib Vitrakin®
08.02.04 Formulary Cancer Drugs Fund Lenalidomide  Revlimid®
08.01.05 Restricted Use Cancer Drugs Fund Lenvatinib Lenvima®
08.01.03 Non Formulary Cancer Drugs Fund Nelarabine Atriance®
08.01.05 Formulary Cancer Drugs Fund Niraparib  Zejula®
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo®
08.02.04 Formulary Cancer Drugs Fund Olaparib Lynparza®
08.02.04 Formulary Cancer Drugs Fund Osimertinib Tagrisso
08.01.03 Formulary Cancer Drugs Fund Pemetrexed 
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig®
08.03.04.02 Formulary Cancer Drugs Fund Radium-223 dichloride Xofigo®
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga®
08.03.04.01 Restricted Use Cancer Drugs Fund Ribociclib  Kisqali®
08.01.05 Formulary Cancer Drugs Fund Rucaparib Rubraca®
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent®
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel®
08.01.05 Formulary Cancer Drugs Fund Tisagenlecleucel Kymriah®
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla®
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa®
08.01.05 Formulary Cancer Drugs Fund Venetoclax  
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge®
Portsmouth and South East Hampshire